A mother’s desperate attempts to save her 22-year-old daughter from a fatal ketamine addiction have come to light during a poignant inquest. Isabelle Sapherson-Moralee, known affectionately as Izzy, succumbed to the devastating effects of her drug abuse after years of struggle. Her death underscores a troubling trend of rising ketamine use among young people in the UK, drawing attention to the urgent need for effective public health interventions.
A Mother’s Heartbreaking Account
Ann Moralee recounted her harrowing experience at the inquest, detailing her relentless efforts over 18 months to secure help for her daughter. The inquest revealed that Isabelle had battled a severe addiction to ketamine, a Class B drug, leading to chronic pain and serious health complications, including a damaged bladder. Just two days before her death in May 2025, she made the heartbreaking decision to leave the hospital, expressing to her mother, “No more hospitals, mum, I can’t do it anymore.”
In her final hours, despite her mother’s pleas to call for medical assistance, Isabelle was resolute in her desire to remain at home. “She knew she was dying that last 48 hours,” Ann Moralee stated, reflecting on the futility of her attempts to save her daughter. Tragically, Isabelle passed away shortly after returning home, highlighting the severity of her deteriorating health.
Rising Ketamine Abuse: A Growing Concern
The inquest revealed alarming statistics regarding the increase in ketamine use among young people in the UK. Since 2015, usage has surged by an astonishing 251.85%, marking it as the highest rise of any single drug during that period. Ketamine, often referred to by street names such as “K” or “Special K,” has been linked to numerous student fatalities, raising significant alarms among health professionals.
Isabelle’s relationship with ketamine began during the COVID-19 lockdowns in 2020, when she moved in with her boyfriend. Ms Moralee only became aware of her daughter’s addiction in late 2023, by which time it had spiralled beyond control. The impact of the drug on Isabelle’s health was profound; she suffered from incontinence and was forced to spend substantial amounts on incontinence pads, ultimately leading to her inability to work six months before her passing.
Missed Opportunities for Intervention
Throughout the inquest, Ann Moralee expressed her frustration with the healthcare system, believing that there were numerous missed opportunities for intervention that could have potentially saved her daughter. After a negative experience with a urologist, Isabelle lost trust in medical professionals, leading to a dangerous cycle of neglect. “She was just seen as a ketamine addict and everything else was ignored,” her mother lamented, emphasising the systemic failures that contributed to her daughter’s decline.
Despite being admitted to the hospital multiple times, Isabelle managed to access ketamine while under care, illustrating the challenges faced by healthcare providers in managing addiction. Ms Moralee described a pivotal moment when her daughter was arrested for suspected ketamine possession, a scenario in which she believed the authorities should have intervened more forcefully for her daughter’s safety. “They had a duty of care,” she asserted, arguing that Isabelle’s capacity to make decisions was compromised by her addiction.
The Vicious Cycle of Addiction
The inquest also featured insights from Scott Davey, a representative from Reach, a drug and alcohol support charity. He highlighted the cyclical nature of ketamine addiction, where users often turn to the drug to alleviate the very pain it causes. “It becomes habitual,” he explained, noting that ketamine’s initial recreational appeal can mask underlying mental health issues, leading to a deeper entrenchment in addiction.
As the inquest continues in Bournemouth, the tragic story of Isabelle Sapherson-Moralee serves as a powerful reminder of the complex interplay between addiction, mental health, and systemic healthcare failures.
Why it Matters
The heartbreaking case of Isabelle Sapherson-Moralee underscores the urgent need for a reevaluation of how addiction is perceived and treated within the healthcare system. With rising rates of ketamine abuse among young people, it is imperative that public health officials and policymakers prioritise effective interventions and support services. The stigma surrounding addiction must be dismantled, ensuring that individuals battling substance use disorders receive compassionate care rather than judgement. This tragedy is not just a personal loss; it is a clarion call for systemic change in how we approach addiction and mental health in our society.
